Disc Medicine (IRON) Assets (2020 - 2026)
Disc Medicine (IRON) reported Assets of $750.2 million for Q1 2026, up 5.77% year-over-year from $709.3 million in Q1 2025, and down 7.02% on a QoQ basis from $806.9 million in Q4 2025.
Disc Medicine (IRON) has 7 years of Assets data on file, last reported at $750.2 million in Q1 2026.
- Quarterly Assets rose 5.77% year-over-year to $750.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $750.2 million (up 5.77% YoY) and the FY2025 annual result came in at $806.9 million, up 62.42% from the prior year.
- Assets declined to $750.2 million in Q1 2026 per IRON's latest filing, from $806.9 million in the prior quarter.
- Across five years, Assets topped out at $806.9 million in Q4 2025 and bottomed at $106.0 million in Q3 2022.
- The 5-year median for Assets is $384.2 million (2023), against an average of $431.4 million.
- The widest annual swing landed in 2022, when Assets sank 34.37%; it then jumped 255.08% in 2023.
- Tracing IRON's Assets over 5 years: stood at $200.2 million in 2022, then jumped by 83.81% to $368.0 million in 2023, then soared by 34.99% to $496.8 million in 2024, then jumped by 62.42% to $806.9 million in 2025, then decreased by 7.02% to $750.2 million in 2026.
- Per Business Quant, the three latest IRON Assets figures stand at $750.2 million (Q1 2026), $806.9 million (Q4 2025), and $630.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | 750.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 750.21 Mn |
| Dec 31, 2025 | 806.88 Mn |
| Sep 30, 2025 | 630.46 Mn |
| Jun 30, 2025 | 665.06 Mn |
| Mar 31, 2025 | 709.27 Mn |
| Dec 31, 2024 | 496.77 Mn |
| Sep 30, 2024 | 495.15 Mn |
| Jun 30, 2024 | 510.22 Mn |
| Mar 31, 2024 | 354.18 Mn |
| Dec 31, 2023 | 368.00 Mn |
| Sep 30, 2023 | 376.50 Mn |
| Jun 30, 2023 | 384.17 Mn |
| Mar 31, 2023 | 243.78 Mn |
| Dec 31, 2022 | 200.21 Mn |
| Sep 30, 2022 | 106.03 Mn |
| Jun 30, 2022 | 113.33 Mn |
| Mar 31, 2022 | 124.29 Mn |
| Dec 31, 2021 | 92.41 Mn |
| Sep 30, 2021 | 155.54 Mn |
| Jun 30, 2021 | 172.42 Mn |
| Mar 31, 2021 | 189.38 Mn |
| Dec 31, 2020 | 8.32 Mn |
| Sep 30, 2020 | 122.36 Mn |